Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R B Belshe

Showing results (21-30 of 143) with videos related to

Pageof 15
Sort By:
The Journal of Infectious Diseases|May 1, 1984
Cold-recombinant influenza A/California/10/78 (H1N1) virus vaccine (CR-37) in seronegative children: infectivity and efficacy against investigational challengeR B Belshe, L P Van Voris
Journal of Medical Virology|February 1, 1986
Protection of weanling hamsters from experimental infection with wild-type parainfluenza virus type 3 (para 3) by cold-adapted mutants of para 3F K Crookshanks-Newman, R B Belshe
The Journal of Infectious Diseases|April 1, 1988
Differences in reactogenicity and antigenicity of acellular and standard pertussis vaccines combined with diphtheria and tetanus in infantsE L Anderson, R B Belshe, J Bartram
Virology|November 1, 1990
Palmitoylation of the influenza A virus M2 proteinR J Sugrue, R B Belshe, A J Hay
The New England Journal of Medicine|November 22, 1973
Letter: Viral hemorrhagic cystitisM A Mufson, R B Belshe, L M Zollar
Journal of Clinical Microbiology|May 1, 1988
Local and systemic antibody responses in high-risk adults given live-attenuated and inactivated influenza A virus vaccinesG J Gorse, R B Belshe, N J Munn
Chest|October 1, 1991
Superiority of live attenuated compared with inactivated influenza A virus vaccines in older, chronically ill adultsG J Gorse, R B Belshe, N J Munn
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 30, 2000
Mucosal bacille calmette-Guérin vaccination of humans inhibits delayed-type hypersensitivity to purified protein derivative but induces mycobacteria-specific interferon-gamma responsesD F Hoft, R M Brown, R B Belshe
The Journal of Infectious Diseases|July 1, 1996
Immune responses stimulated by percutaneous and intradermal bacille Calmette-GuérinE B Kemp, R B Belshe, D F Hoft
Journal of Clinical Microbiology|September 1, 1986
Safety of and serum antibody response to cold-recombinant influenza A and inactivated trivalent influenza virus vaccines in older adults with chronic diseasesG J Gorse, R B Belshe, N J Munn
Pageof 15

Showing results (21-30 of 143) with videos related to

Sort By:
Pageof 15
The Journal of Infectious Diseases|May 1, 1984
Cold-recombinant influenza A/California/10/78 (H1N1) virus vaccine (CR-37) in seronegative children: infectivity and efficacy against investigational challengeR B Belshe, L P Van Voris
Journal of Medical Virology|February 1, 1986
Protection of weanling hamsters from experimental infection with wild-type parainfluenza virus type 3 (para 3) by cold-adapted mutants of para 3F K Crookshanks-Newman, R B Belshe
The Journal of Infectious Diseases|April 1, 1988
Differences in reactogenicity and antigenicity of acellular and standard pertussis vaccines combined with diphtheria and tetanus in infantsE L Anderson, R B Belshe, J Bartram
Virology|November 1, 1990
Palmitoylation of the influenza A virus M2 proteinR J Sugrue, R B Belshe, A J Hay
The New England Journal of Medicine|November 22, 1973
Letter: Viral hemorrhagic cystitisM A Mufson, R B Belshe, L M Zollar
Journal of Clinical Microbiology|May 1, 1988
Local and systemic antibody responses in high-risk adults given live-attenuated and inactivated influenza A virus vaccinesG J Gorse, R B Belshe, N J Munn
Chest|October 1, 1991
Superiority of live attenuated compared with inactivated influenza A virus vaccines in older, chronically ill adultsG J Gorse, R B Belshe, N J Munn
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 30, 2000
Mucosal bacille calmette-Guérin vaccination of humans inhibits delayed-type hypersensitivity to purified protein derivative but induces mycobacteria-specific interferon-gamma responsesD F Hoft, R M Brown, R B Belshe
The Journal of Infectious Diseases|July 1, 1996
Immune responses stimulated by percutaneous and intradermal bacille Calmette-GuérinE B Kemp, R B Belshe, D F Hoft
Journal of Clinical Microbiology|September 1, 1986
Safety of and serum antibody response to cold-recombinant influenza A and inactivated trivalent influenza virus vaccines in older adults with chronic diseasesG J Gorse, R B Belshe, N J Munn
Pageof 15